Compared to placebo (3.3%, 3.2 kg), patients lost a mean of 13.4% (13.5 kg) of body weight in the 10 mg group and 15.7% (15.6 kg) of body weight in the 15 mg group
In patients with type 2 DM, GLP-1R agonists have demonstrated a reduction in circumferential strain and improvement in markers of diastolic function, a key component of diabetic cardiomyopathy and the risk of developing heart failure
Rapid improvements in blood sugar control can temporarily worsen existing retinopathy through a phenomenon known as early worsening
The key principle is achieving gradual, sustained weight loss rather than rapid reduction
For all the buzz surrounding Ozempic and similar GLP-1 drugs for weight loss, there are also plenty of concerns about potential serious or long-term side effects
Provider or Pharmacy: The cost may vary depending on whether you are obtaining semaglutide GLP-1 through a medical spa, doctors office, or pharmacy